CA
Calithera Biosciences, Inc.
CALA · OTC
$0.00 +0.00% (+$0.00)
1M +200.00%
Market Cap $1.95K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/B 0.00x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 47.69%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 184.41%
Asset turnover 0.00x
ROA 65.79%
Debt
99 /100
Low Debt/Equity 0.08x
Net debt/EBITDA 0.62x
Current ratio 3.60x
Stability
37 /100
Moderate Beta -1.28x
Profitable years 0
EPS volatility 46.73%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o CALA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stephanie Wong
Employees
8
Headquarters
South San Francisco
Nadchodzące wydarzenia
17 LIS
Earnings
Upcoming earnings report